2
Total investments
0
Early stage
0
Mid stage
1
Late stage
7y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2022
SubjectWell provides the most accurate, diverse, predictable, and patient-centric platform that connects patients and caregivers to breakthrough healthcare opportunities. With a Patient Network of 13 million+ patients interested in pursuing new treatments, including over 6 million people of color, combined with innovative patient engagement and retention strategies, SubjectWell has helped sponsors, Clinical Research Organizations (CROs), clinical sites, and site networks connect thousands of patients to clinical studies and new treatments across all therapeutic areas.
Investor
2019
Concord Technologies is a leading provider of secure document exchange, intelligent document processing, and interoperability solutions to healthcare providers, payers, and other highly regulated businesses.
For over twenty years, billions of sensitive records containing valuable patient information have been reliably, accurately, and securely sent and received across Concord’s digital health network. Today, the company processes over five billion pages of protected data annually.
The company is also recognized for its best-in-class development of new artificial intelligence technologies, including Concord’s Practical AI™ approach to solving the most pervasive administrative challenges in the healthcare industry, and for its industry-leading applications that help its customers grow and manage their business.
Experience · 4 entries
All (4)
Investments (2)
2022
Investor
2022
SubjectWell provides the most accurate, diverse, predictable, and patient-centric platform that connects patients and caregivers to breakthrough healthcare opportunities. With a Patient Network of 13 million+ patients interested in pursuing new treatments, including over 6 million people of color, combined with innovative patient engagement and retention strategies, SubjectWell has helped sponsors, Clinical Research Organizations (CROs), clinical sites, and site networks connect thousands of patients to clinical studies and new treatments across all therapeutic areas.
2019
Investor
2019
Concord Technologies is a leading provider of secure document exchange, intelligent document processing, and interoperability solutions to healthcare providers, payers, and other highly regulated businesses.
For over twenty years, billions of sensitive records containing valuable patient information have been reliably, accurately, and securely sent and received across Concord’s digital health network. Today, the company processes over five billion pages of protected data annually.
The company is also recognized for its best-in-class development of new artificial intelligence technologies, including Concord’s Practical AI™ approach to solving the most pervasive administrative challenges in the healthcare industry, and for its industry-leading applications that help its customers grow and manage their business.
2016
Senior Vice President | Software & HealthTech
2016
Cascadia is the second largest independent advisory only investment bank in the U.S. Founded in 1999, we serve both private and public growth companies, and financial sponsors around the globe. We are client-focused, strategic partners that work with companies throughout their life cycle.
We are industry specialists that simplify complex issues. We believe in the potential of your business, and help you achieve your growth and liquidity goals. Our industry focus areas include:
• Business Services
• Consumer & Retail
• Energy & Applied Technology
• Food, Beverage & Agribusiness
• Healthcare
• Industrials
• Technology
2014
Investment Banking | Tech Mergers & Acquisitions
2014
Financial Technology Partners ("FT Partners") is the only investment banking firm focused exclusively on the financial technology ("FinTech") sector. We broadly define the sector as the dynamic convergence of technology-based solutions and financial services. FT Partners was recently recognized as "Dealmaker of the Year" and "Investment Banking Firm of the Year" by The M&A Advisor.
The firm was founded by Steve McLaughlin, Managing Partner, formerly a senior investment banker in Goldman Sachs & Co.s Financial Technology Group and Financial Institutions Group in New York and San Francisco. The firms senior members are all highly experienced investment bankers formerly with the financial technology, M&A and investment banking groups of principally Goldman, Sachs & Co.
Clients want and deserve the best in overall investment banking services, industry knowledge, relationships and senior level experience. In the complex financial technology sector, we believe no other firm offers a higher set of skills, expertise and mission critical advice to leading CEOs and industry decision makers. When you want to explore your firms full potential, consider FT Partners full suite of strategic and financial advisory services. With years of transaction experience on some of the largest transactions in history, we bring our unique approach to your firm to maximize value to your shareholders.
